The EVOLVE China Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

412

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

December 31, 2020

Conditions
Coronary Artery Disease
Interventions
DEVICE

SYNERGY Investigational Device

percutaneous coronary intervention

DEVICE

PE Plus Investigational Device

percutaneous coronary intervention

Trial Locations (14)

110015

Shenyang Northern Hospital (The General Hospital of Shenyang Military Region), Shenyang

Unknown

Beijing Affiliated Hospital of Armed Police Medical College, Beijing

Beijing Hospital of the Ministry of Health, Beijing

Cardiovascular Institute and Fu Wai Hospital, Beijing

Peking University First Hospital, Beijing

Daqing General Oil Field Hospital, Daqing

Guangdong Cardiovascular Institute of Guangdong Provincial Hospital, Guangzhou

Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou

Shengjing Hospital of China Medical University, Shengyang

TEDA International Cardiovascular Hospital, Tianjin

Logistics University of PAPF Affiliated Hospital, Tianjing

Wuhan Asia Heart Hospital, Wuhan

First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an

Xijing Hospital, Fourth Military Medical University, Xi'an

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY